-
Featured Authors
Archive
- April 2013 (4)
- March 2013 (3)
- February 2013 (1)
- January 2013 (1)
- October 2012 (2)
- September 2012 (1)
- August 2012 (3)
- June 2012 (4)
- May 2012 (4)
- April 2012 (2)
- March 2012 (2)
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (4)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: The One-on-One Compass
#BIF2012 Company Snapshot: Chimerix
Our next Company Snapshot for next week’s BIO Investor Forum is Chimerix. They will be presenting on Tuesday, at 1:30pm, and will also be participating in a panel at the event, Choose Your Own Adventure — Late Stage Private Company Decisions on Wednesday. To learn more about the company before you get onsite, continue reading! Company Snapshot What is your company’s lead product or technology? Chimerix’s lead product is CMX001, a novel, broad-spectrum, oral antiviral that inhibits double-stranded Read More >
#BIF2012 Company Snapshot: Profil Institute for Translational Medicine
For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of the presenting companies at the event, Profil Institute for Translational Medicine, Inc. To find out more about this organization and what they’re doing for biotech, please read below! You’ll be able to see their presentation onsite, Wednesday 10/10 at 9:30am in the Presidio Room. Company Snapshot What is your company’s lead product or technology? Based on collaborations with biopharma, Read More >





